Rep. Waxman urges Governor Schwarzenegger to maintain a life-saving ban on the summer sale of raw Gulf Coast Oysters.
Reps. Waxman and Dingell ask the DOD IG to investigate the December 19 waiver given by the Corps of Engineers to Halliburton, citing new evidence that this unusual waiver -- which relieved Halliburton of its obligation to provide data to justify its high gasoline prices -- may have been awarded on false premises.
Reps. Waxman and Sherrod Brown write HHS Secretary Thompson, OMB Director Bolten, and White House Counsel Alberto Gonzales about reports that a pharmaceutical benefits management company CEO may have helped write provisions of the recent Medicare law that govern the prescription drug card program.
Rep. Waxman, along with Sens. Lieberman, Levin, Akaka, Durbin, and Reps. Skelton and Danny Davis, express serious concerns about an initial proposal for a new Defense Department labor relations system that effectively eliminates collective bargaining and makes changes to internal union procedures which have no relation to the Department’s national security mission.
Reps. Waxman and Putnam urge USDA Secretary Veneman to support a pilot program to promote the consumption of fruits and vegetables in the upcoming reauthorization of the Federal Special Supplemental Nutrition Program for Woman, Infants, and Children.
Forty eight members of Congress write FDA about the delay in the consideration of the application for over-the-counter status for the emergency contraception drug Plan B.
In light of recent reports that top NIH scientists received consulting payments worth hundreds of thousands or even millions of dollars from drug manufacturers with an interest in their work, Reps. Waxman and Sherrod Brown write ten large pharmaceutical manufacturers – Merck, Johnson & Johnson, Wyeth, Schering-Plough, Pfizer, Bristol-MyersSquibb, Eli Lilly, Abbott, Amgen, and Allergan – to request information on their financial arrangements with NIH scientists.
Reps. Waxman and Dingell request a copy of Halliburton's internal "Tiger Team" memo which reportedly describes major deficiencies in the company's accounting and control systems.
Rep. Waxman, Chairman Davis, and Congresswoman Norton seek information on whether EPA adequately carried out its responsibility to prevent lead contamination in tap water in the District of Columbia.
In response to reports that the true cost of the Medicare prescription drug legislation was concealed, 19 committee members demand the release of the cost estimates prepared by the Administration during congressional consideration of the legislation.
Reps. Waxman and Slaughter reveal that the Administration may have misinformed the public about both the number of viable human embryonic stem cell lines available for research and the motivation behind the recent dismissal of a distinguished cell biologist from the President’s Council on Bioethics.
At a Committee hearing and in a briefing memo to colleagues, Rep. Waxman details new information from the Defense Contract Audit Agency, GAO, and the Defense Energy Support on Halliburton’s work in Iraq.
In a report prepared for Reps. Waxman and Tierney, GAO assesses what is known about the effectiveness of the missile defense system and how the Defense Department's Missile Defense Agency has addressed the Director, Operational Test and Evaluation recommendations on the missile defense testing program.
Rep. Waxman, Chairman Davis, and Congresswoman Norton urge EPA to address weaknesses in the drinking water lead rule, including the lack of enforceable standards and shortcomings in public notification requirements.
In a letter to Chairman Davis, Rep. Waxman requests a hearing on the allegations that the HHS Actuary was told he would be fired if he shared with Congress estimates on the true costs of the Medicare prescription drug proposal. In a letter to HHS Secretary Thompson, Rep. Waxman threatens legal action under the "Seven Member Rule" if the Secretary continues to refuse to release the cost estimates.
Fifty-two members of the California House delegation write EPA to express support for a waiver that would allow the state to sell cleaner blends of gasoline without the oxygenates mandated by the Clean Air Act.
Rep. Waxman and the five minority members of the Civil Service Subcommittee express concerns about a new Department of Homeland Security personnel system that would infringe on employee collective bargaining and appeal rights without furthering the Department’s ability to perform its mission.
Following a Government Reform Committee hearing, Rep. Waxman, Chairman Davis, Congresswoman Norton, and Rep. Van Hollen detail further questions on the roles and responsibilities of EPA, the District of Columbia Water and Sewer Authority, and the U.S. Army Corps of Engineers' Washington Aqueduct in preventing lead contamination in the District's drinking water supply.
Reps. Waxman and Tierney ask the Defense Department to explain the decision to retroactively classify 50 specific recommendations, set forth by independent Pentagon evaluators, that are highly critical of the national missile defense system testing program.
Rep. Waxman objects to proposed drug approval standards, being circulated by the Administration for consideration at a conference next week in Botswana, that could block the use of the low-cost drugs needed to save the lives of millions of people living with HIV in Africa and other developing regions.
Rep. Waxman questions White House Counsel Alberto Gonzales on reports that he placed calls to members of the September 11 Commission during the testimony of former National Coordinator for Security and Counterterrorism Richard Clarke.
A new report prepared for Rep. Waxman and 12 other Los Angeles-Long Beach area members details the local impact of Congress's failure to pass a temporary federal extension of unemployment benefits.
A new report released by Rep. Waxman shows that the Administration, at the request of the U.S. chemical industry, mounted a campaign to block the efforts of the European Union to require company assessments of the risks of industrial chemicals.
In light of reports that the Administration is looking at short-term measures to address record-high gasoline prices, Reps. Waxman, Eshoo, Capps, Solis, and Lofgren write the President to call attention to California Governor Schwarzenegger's request for waiver of federal oxygenate requirements -- a step that could be taken immediately to reduce gasoline prices in the state.
This report examines how the Bush Administration responded to a landmark effort by the European Union to reduce the risks of chemical exposure. The report is based on documents obtained by the Environmental Health Fund, a small nonprofit environmental organization, and provided to the Special Investigations Division. These documents provide a case study in how a powerful special interest can influence the nation’s foreign policy.
Displaying Items 26 to 50 of 155: